Envoy Medical, Inc. (COCH): auditor change — Envoy Medical restating Q3 2023 financials due to FPA accounting error; prior statements no longer reliable

Envoy Medical, Inc.

Audit committee on Dec 14, 2023 concluded Q3 2023 unaudited financials should no longer be relied upon.
Error in accounting for forward purchase agreement (FPA); prepayment to be reclassified from assets to equity.
Restatement will also record maturity and share consideration as non-current liabilities.
Material weakness in internal control over financial reporting as of Sept 30, 2023, previously disclosed.

item 4.02

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.92

Envoy Medical, Inc. reported that prior financial statements should not be relied upon.

Action: non reliance
Auditor: Grant Thornton LLP

Exact text from the filing

On December 14, 2023, the audit committee (the "Audit Committee") of the board of directors of Envoy Medical, Inc. (the "Company"), after considering the recommendations of management, concluded that the Company's previously issued unaudited interim financial statements included in the Company's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2023 (the "Previous Financial Statements" and such period, the "Affected Period"), should no longer be relied upon.

View on SEC.gov

Browse all auditor changes →

Envoy Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-23-096921

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.